Tratamiento con Hidroxicloroquina en pacientes con COVID-19 Informe rápido de evaluacion de tecnología sanitaria

Hasdeu, Santiago; Montero, Guadulupe; Tortosa, Fernando; Sanguine, Verónica; Balaciano, Giselle; Izcovich, Ariel; Ragusa, Martin.
Rev. argent. salud publica ; 12(Suplemento Covid-19): 1-9, 23 de Julio 2020.
Artículo en Español | BINACIS, BRISA, ARGMSAL, LILACS | ID: biblio-1141084

Documentos relacionados

  1. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: Review and Appraisal of Current Evidence.
  2. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
  3. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
  4. Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update.
  5. Role for antimalarials in the management of COVID-19.
  6. Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.
  7. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
  8. Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.
  9. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
  10. Emerging prophylaxis strategies against COVID-19.